← Leaderboards
Douglas Barrows
Rockefeller University
$179,478
Attributed
$179,478
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $63.7K · FY2017–19$100K$75K$50K$25K$0
'17
'18
'19
Funding mix
By agency
NIH$179,478 · 1
By mechanism
F32$179,478 · 1
Top collaborators
No co-investigators on record.
Most similar at Rockefeller University
Same institution · by research overlap
- Jeffrey Victor Ravetch$66,226,718
- Jean-Laurent Casanova$36,806,361
- Paul Greengard$29,785,859
- Robert G Roeder$31,979,333
- Roderick Mackinnon$13,010,519
Others in their field
Other Emerging Leaders on “Advanced Disease”
- Bambra Strokes · Ppd Development Lp$526,656,217
- Chanza Baytop · Westat, Inc.$271,217,917
- Kimberly Smith · Ppd Development Lp$116,656,661
- Klaus Romero · Critical Path Institute$88,602,036
- Marlene Ann Cooper · Harvard University D/B/A Harvard School Of Public Health$71,439,892
- Ted Ross · University Of Georgia$59,913,818
Research focus
Advanced DiseaseActivating Transcription FactorBiochemicalBiologicalAffectBraf GeneCancer ControlCancer GenomeCancer ModelCancer TypeBiologyCd58 AntigensCellsChromatinChromatin FiberCollaborationsColorectal CancerCombatComplexCreb1 GeneCrispr/Cas TechnologyCuesCareerDrug Resistance
Grant awards (3)
Identification of MSKs as critical integrators of chromatin and transcription factor activation in melanoma$63,746
F32 · FY2019 · CA · contact PI
Identification of MSKs as critical integrators of chromatin and transcription factor activation in melanoma$59,038
F32 · FY2018 · CA · contact PI
Identification of MSKs as critical integrators of chromatin and transcription factor activation in melanoma$56,694
F32 · FY2017 · CA · contact PI